Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.
复制标题

DOI:
10.1016/j.ccr.2008.12.018
复制
发表时间:
2009-02-03
期刊:
影响因子:
50.3
通讯作者:
Yu H
Yu H
中科院分区:
医学1区
文献类型:
--
作者:
Kortylewski M;Xin H;Kujawski M;Lee H;Liu Y;Harris T;Drake C;Pardoll D;Yu H

文献摘要

参考文献

被引文献

相似文献

肿瘤和免疫细胞之间的相互作用可以增强或抑制癌症进展。我们在这里表明,肿瘤微环境中的Stat 3信号诱导促癌细胞因子IL-23,同时抑制中枢抗癌细胞因子IL-12,从而将肿瘤免疫的平衡转向致癌作用。Stat 3通过IL-23/p19基因的直接转录激活诱导IL-23的表达,IL-23主要由肿瘤相关巨噬细胞产生。此外,Stat 3抑制肿瘤相关树突状细胞中NF-κB/c-Rel依赖性IL-12/p35基因的表达。肿瘤相关调节性T细胞(Treg)表达IL-23受体(IL-23 R),其激活该细胞类型中的Stat 3,导致Treg特异性转录因子Foxp 3和免疫抑制细胞因子IL-10的上调。这些结果表明,Stat 3促进IL-23介导的促癌免疫应答,同时抑制IL-12依赖性抗肿瘤免疫。最近的研究表明,两种相关的细胞因子,IL- 23和IL- 12,在肿瘤发生中起相反的作用。然而,调节肿瘤微环境中这些细胞因子之间平衡的潜在机制尚未阐明。IL-23促进肿瘤免疫逃避的机制还有待探索。我们的研究结果表明,肿瘤微环境中的Stat 3信号传导调节IL-12/IL-23平衡,并且IL- 23部分地通过IL-23受体依赖性Stat 3激活来增强肿瘤微环境中调节性T细胞的免疫抑制活性。由于Stat 3是癌症中通常激活的信号通路的汇聚点,我们的数据揭示了致癌通路调节免疫微环境以促进肿瘤发展的机制。
Interactions between tumor and immune cells either enhance or inhibit cancer progression. We show here that Stat3 signaling within the tumor microenvironment induces a pro-carcinogenic cytokine, IL-23, while inhibiting a central anti-carcinogenic cytokine, IL-12, thereby shifting the balance of tumor immunity towards carcinogenesis. Stat3 induces expression of IL-23, which is mainly produced by tumor-associated macrophages, via direct transcriptional activation of the IL-23/p19 gene. Furthermore, Stat3 inhibits NF-κB/c-Rel-dependent IL-12/p35 gene expression in tumor-associated dendritic cells. Tumor-associated regulatory T cells (Treg) express IL-23 receptor (IL-23R) which activates Stat3 in this cell type, leading to upregulation of the Treg-specific transcription factor, Foxp3, and the immunosuppressive cytokine, IL-10. These results demonstrate that Stat3 promotes IL-23-mediated pro-carcinogenic immune responses while inhibiting IL-12-dependent anti-tumor immunity. Recent studies suggest that two related cytokines, IL- 23 and IL- 12, play opposite roles in carcinogenesis. However, the underlying mechanisms regulating the balance between these cytokines in the tumor microenvironment have not been elucidated. Mechanisms by which IL-23 promotes tumor immune evasion also remain to be explored. Our results reveal that Stat3 signaling in the tumor microenvironment regulates the IL-12/IL-23 balance and further, that IL- 23 enhances the immunosuppressive activity of regulatory T cells within the tumor microenvironment, in part via IL-23 receptor dependent Stat3 activation. Because Stat3 is a point of convergence for signaling pathways commonly activated in cancer, our data reveal a mechanism by which oncogenic pathways regulate the immune microenvironment to promote tumor development.
DOI: 10.1016/s1074-7613(00)00070-4
发表时间: 2000-11-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Oppmann, B;Lesley, R;Kastelein, RA
通讯作者: Kastelein, RA
DOI: 10.1084/jem.20010938
发表时间: 2002-02-04
期刊: The Journal of experimental medicine
影响因子: --
作者:
Gerosa F;Baldani-Guerra B;Nisii C;Marchesini V;Carra G;Trinchieri G
通讯作者: Trinchieri G
DOI: 10.1038/ni1213
发表时间: 2005-07-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Dunn, GP;Bruce, AT;Schreiber, RD
通讯作者: Schreiber, RD
DOI: 10.1038/35074122
发表时间: 2001-04-26
期刊: NATURE
影响因子: 64.8
作者:
Shankaran, V;Ikeda, H;Schreiber, RD
通讯作者: Schreiber, RD
DOI: 10.4049/jimmunol.172.5.2827
发表时间: 2004-03-01
影响因子: 4.4
作者:
Ghilardi, N;Kljavin, N;de Sauvage, FJ
通讯作者: de Sauvage, FJ